Psychae Therapeutics

Carlton, Australia

Psychae Therapeutics focuses on developing medical-grade, botanically derived treatments to address serious mental health challenges.

$2.9M raised

Nov 2023

Pre-Seed

Biotechnology Health Care Medical Therapeutics

Top Investors

University of Melbourne Tin Alley Ventures

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Psychae Therapeutics

How much funding has Psychae Therapeutics raised?

Psychae Therapeutics has raised $2.9M in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2023.

Who are Psychae Therapeutics's investors?

Psychae Therapeutics's investors include University of Melbourne, Tin Alley Ventures.

Where is Psychae Therapeutics headquartered?

Psychae Therapeutics is headquartered in Carlton, Australia.

What does Psychae Therapeutics do?

Psychae Therapeutics focuses on developing medical-grade, botanically derived treatments to address serious mental health challenges.

What stage is Psychae Therapeutics at?

Psychae Therapeutics is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 13, 2023.

MLA

"Psychae Therapeutics — Funding & Investors." VCBacked, November 13, 2023, https://www.vcbacked.co/company/psychae-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Psychae Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/psychae-therapeutics

Wikipedia (cite web)

{{cite web |title=Psychae Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/psychae-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 13, 2023.